Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: trūFreeze® Palliative Esophageal Cancer [NA]
A completed clinical trial evaluating trūFreeze for palliation of esophageal cancer. The study was sponsored by US Endoscopy Group Inc.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Esophageal Squamous Cell Cancer Surveillance With Cytosponge [NA]
The clinical trial evaluating Cytosponge-based surveillance for esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers [Phase 2]
Phase 2 trial evaluating APX005M in combination with concurrent chemoradiation for resectable esophageal and gastroesophageal junction cance…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Early Detection of Esophageal Cancer
An NCI-sponsored clinical trial evaluating early detection of esophageal cancer has been terminated. The study also related to stomach neopl…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Raman Probe for In-vivo Diagnostics (During Oesophageal) Endoscopy [NA]
This clinical trial evaluating a Raman spectroscopy probe for in-vivo diagnostics during esophageal endoscopy has completed, investigating B…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancer [Phase 2]
Phase 2 trial evaluating chemoradiotherapy plus immunotherapy followed by surgery for esophageal cancer in a neoadjuvant setting.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) [Phase 2]
Phase 2 trial evaluating thalidomide to prevent or treat RCCEP induced by camrelizumab in patients with lung or esophageal cancers is ongoin…
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating an anti-PD-L1 agent in combination with chemotherapy and/or radiotherapy for esophageal cancer has completed, w…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED) [Phase 2]
Phase 2 PROCEED trial evaluating pembrolizumab with radiotherapy and chemotherapy as neoadjuvant treatment for locally advanced esophageal a…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer [Phase 2]
Phase 2 trial update for KeyLargo combining pembrolizumab with oxaliplatin and capecitabine in gastric and esophageal cancer; study complete…
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to Radiochemotherapy [Phase 2, Phase 3]
A phase 2/3 trial comparing systematic surgery to surveillance with rescue surgery in operable esophageal cancer patients who had a complete…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer [Phase 3]
Phase 3 trial comparing simultaneous modulated accelerated boost to standard-dose radiotherapy in esophageal cancer is ongoing with status U…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL [Phase 1, Phase 2]
Phase 1/2 trial update for CX-2029 in solid tumors and DLBCL completed; aims to identify safe and active dose levels.
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer [Phase 3]
A Phase 3 study comparing SHR-1210 to investigator's choice chemotherapy in advanced esophageal cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308) [Phase 3]
A Phase 3 trial evaluating neoadjuvant chemoradiotherapy with either docetaxel or vinorelbine plus cisplatin for esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma [Phase 2]
A Phase 2 clinical trial update evaluating perioperative Adebrelimab plus chemotherapy for esophageal and esophagogastric junction carcinoma…
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal Resection [Phase 4]
Phase 4 clinical trial examining goal-directed fluid therapy to reduce postoperative complications after esophageal resection.
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Intrathoracic Esophagogastric Anastomosis After Robot Assisted Minimally Invasive Esophagectomy Using STRATAFIX
A completed clinical trial evaluating intrathoracic esophagogastric anastomosis after robot-assisted minimally invasive esophagectomy using …
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrence [Phase 2]
Phase 2 trial evaluating OBI-833/OBI-821 in locally advanced Globo H-positive esophageal cancer for recurrence is ongoing with unknown statu…
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial [Phase 3]
Phase 3 clinical trial update for SARONG-II evaluating surveillance after resection of esophageal and gastric cancer; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer [Phase 2]
Phase 2 clinical trial evaluating afatinib plus paclitaxel in advanced HER2-positive, trastuzumab-refractory esophagogastric cancer has comp…
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer [Phase 2]
Phase 2 trial evaluating CAPOX chemotherapy plus Bevacizumab and Trastuzumab in HER2-positive metastatic esophagogastric cancer completed, w…
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer [Phase 2]
Phase 2 trial update on neoadjuvant treatment for resectable esophageal cancer using sintilimab and anlotinib in combination with chemothera…
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Neoadjuvant Treatment of Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 neoadjuvant trial evaluating cadonilimab plus albumin-paclitaxel, cisplatin, and fluorouracil for resectable locally advanced esopha…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma [Phase 3]
Phase 3 clinical trial comparing 61.2 Gy versus 50.4 Gy radiotherapy dose for locally advanced esophageal carcinoma (esophageal squamous cel…